Stockreport

AIM ImmunoTech Expands Patent Portfolio with New Netherlands Composition and Methods Patent Covering Ampligen for Use in the Post-COVID Condition of Fatigue [Yahoo! Finance]

AIM ImmunoTech Inc.  (AIM) 
PDF Patent Office (Octrooicentrum Nederland) has granted Patent No. 2,032,813 — a compositions and methods patent — covering Ampligen ® (rintatolimod) for use in the treatme [Read more]